Adverse events following COVID-19 vaccination in Kwara State, North-central Nigeria
03 medical and health sciences
0302 clinical medicine
Public aspects of medicine
RA1-1270
3. Good health
Research Article
DOI:
10.1371/journal.pgph.0000835
Publication Date:
2022-08-15T17:25:46Z
AUTHORS (6)
ABSTRACT
Safe and effective vaccination remains the mainstay of control COVID-19 because there is still no universally recommended treatment. This strategy however being threatened by vaccine hesitancy resistance due to fear adverse events safety concerns. It is, therefore, necessary study post-vaccination (AE) in various populations geographical areas. The objective this was analyze following five major immunization centers Kwara State Nigeria. A retrospective descriptive AstraZeneca that were reported from State, North-central Nigeria March July 2021 carried out. Statistical Package for Social Science version 26 used analysis. Adverse event classification severity compared based on age, gender, time onset dose type using Chi-square test. incidence AE 1.6%. There female predominance (51.6%) a mean age 41.6±13.7 years. Most (95.8%) systemic mild (81.1%) without requirement any therapeutic intervention. Fatal outcome not 2 days most cases (45.3%). No significant association found between variables studied severity. low nature will add body knowledge regarding may eventually impact uptake.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....